Lindbrook Capital »

Caribou Biosciences shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Caribou Biosciences (CRBU) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Caribou Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Caribou Biosciences held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caribou Biosciences by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.6k 703 5.14
2023-12-31 $4.0k 703 5.73
2023-09-30 $1.3k 269 4.78
2022-12-31 $357 57 6.28

More positions owned by Lindbrook Capital

Vanguard Total Stk Mkt Etf (VTI)
Vanguard Total Intl Stock Idex Etf Etf (VXUS)
Golub Cap Bdc Cef (GBDC)
Apple Stock (AAPL)
Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Russell 1000 Growth Etf Etf (IWF)
Nvidia Corporation Stock (NVDA)
Microsoft Stock (MSFT)
Rpar Risk Parity Etf Etf (RPAR)
Ishares Russell 1000 Value Etf Etf (IWD)
Amazon.com Stock (AMZN)
Powershares Qqq Tr Etf (QQQ)
Oaktree Specialty Lending Corp Cef (OCSL)
Vertex Pharmaceuticals In Stock (VRTX)
Broadcom Stock (AVGO)

View all positions for Lindbrook Capital

Top funds holding Caribou Biosciences

BlackRock
Partner Fund Management
Avidity Partners Management
Vanguard Group
Point72 Asset Management
Paradigm Biocapital Advisors
Elmwood Wealth Management
Dimensional Fund Advisors
Bank of America Corporation
Candriam Luxembourg S.C.A.
Kynam Capital Management
Rokos Capital Management
Charles Schwab Investment Management
Goldman Sachs Group
Maverick Capital

View all funds holding Caribou Biosciences